Successful Treatment of Severe Tuberculosis With Contezolid Add-On Regimen in a Patient Complicated With Acute Thrombocytopenia: A Case Report

Polypharmacy in managing severe tuberculosis patients usually poses a risk of adverse drug reactions. Contezolid is a new oxazolidinone antibiotic showing good in vitro and in vivo activity against Mycobacterium tuberculosis . Contezolid add-on regimen shows promising efficacy and safety results in managing severe tuberculosis patients complicated with acute thrombocytopenia.